These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1387016)

  • 41. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility of linked recognition of virus antigen as a helper determinant with a target antigen in the consideration of clinical application of virus-helper system in tumor immunity.
    Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2071-2. PubMed ID: 2963082
    [No Abstract]   [Full Text] [Related]  

  • 43. Overcoming T cell ignorance by providing costimulation. Implications for the immune response against cancer.
    Chen L
    Adv Exp Med Biol; 1998; 451():159-65. PubMed ID: 10026867
    [No Abstract]   [Full Text] [Related]  

  • 44. Lymphokine preparations: a new approach to cancer immunotherapy.
    Papermaster BW; Kaltenbach ML
    Mo Med; 1978 Dec; 75(12):607-9, 612. PubMed ID: 723839
    [No Abstract]   [Full Text] [Related]  

  • 45. Highly malignant tumor variants retain tumor-specific antigens recognized by T helper cells.
    Van Waes C; Urban JL; Rothstein JL; Ward PL; Schreiber H
    J Exp Med; 1986 Nov; 164(5):1547-65. PubMed ID: 2945891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pilot study of immunization with HLA-A2 matched allogeneic melanoma cells that secrete interleukin-2 in patients with metastatic melanoma.
    Hum Gene Ther; 1992 Dec; 3(6):677-90. PubMed ID: 1482708
    [No Abstract]   [Full Text] [Related]  

  • 47. Tumor immunotherapy.
    Manson LA
    Immunol Today; 1989 Feb; 10(2):36. PubMed ID: 2787650
    [No Abstract]   [Full Text] [Related]  

  • 48. Cytokine gene transfer in tumor cells as an approach to antitumor therapy.
    Colombo MP; Mattei S; Parmiani G
    Int J Clin Lab Res; 1992; 21(4):278-82. PubMed ID: 1591380
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen-presenting cells constitutively bind tumor antigens in the tumor-bearing state in vivo to construct an effective immunogenic unit.
    Shimizu J; Zou JP; Ikegame K; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1991 Mar; 82(3):262-5. PubMed ID: 1902448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toward a genetic analysis of tumor rejection antigens.
    Boon T
    Adv Cancer Res; 1992; 58():177-210. PubMed ID: 1546558
    [No Abstract]   [Full Text] [Related]  

  • 51. Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells.
    Kirkin AF; Dzhandzhugazyan KN; Guldberg P; Fang JJ; Andersen RS; Dahl C; Mortensen J; Lundby T; Wagner A; Law I; Broholm H; Madsen L; Lundell-Ek C; Gjerstorff MF; Ditzel HJ; Jensen MR; Fischer W
    Nat Commun; 2018 Mar; 9(1):785. PubMed ID: 29511178
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cells and tumors.
    Maas RA; Dullens HF; Den Otter W
    Immunol Today; 1992 Feb; 13(2):78-9. PubMed ID: 1575895
    [No Abstract]   [Full Text] [Related]  

  • 53. Exploiting the immune system's own strategies for immunotherapy.
    Lanzavecchia A
    Immunol Today; 1988 Jun; 9(6):167-8. PubMed ID: 3267175
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 55. Cellular mechanisms of tumor rejection in vivo and enhanced induction of anti tumor protective immunity applicable to tumor-specific immunotherapy.
    Fujiwara H; Hamaoka T
    Prog Exp Tumor Res; 1988; 32():69-103. PubMed ID: 2967523
    [No Abstract]   [Full Text] [Related]  

  • 56. Antitumor and antimetastatic activity of interleukin-12.
    Hendrzak JA; Brunda MJ
    Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():65-83. PubMed ID: 8815011
    [No Abstract]   [Full Text] [Related]  

  • 57. The role of contrasuppression in tumor regression.
    Flood PM; Friedman A; Freedman J; Horvat B; Reuter P; Ptak W
    Immunol Res; 1988; 7(1):12-22. PubMed ID: 2897407
    [No Abstract]   [Full Text] [Related]  

  • 58. Experimental immunotherapy of breast cancer using alpha interferon conjugated to monoclonal antibody Mc5.
    Ozzello L; De Rosa CM; Blank EW; Cantell K; Ceriani RL; Habif DV
    Adv Exp Med Biol; 1994; 353():35-46. PubMed ID: 7985540
    [No Abstract]   [Full Text] [Related]  

  • 59. Cytokines and cancer: experimental systems.
    Blankenstein T; Rowley DA; Schreiber H
    Curr Opin Immunol; 1991 Oct; 3(5):694-8. PubMed ID: 1755987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunology of experimental oncogenesis.
    Embleton MJ
    Curr Opin Immunol; 1989 Jun; 1(5):867-71. PubMed ID: 2529875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.